Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.

Transcriptomic differences between mouse tumor-infiltrating and splenic regulatory T cells with or without Treg-specific loss of CD177

Transciption profiling of leptin receptor-expressing neurons in the Nucleus of the Solitary Tract

The transcriptional coactivator CBP/p300 is an evolutionarily conserved node that promotes longevity in response to mitochondrial stress [Mus musculus]

The transcriptional coactivator CBP/p300 is an evolutionarily conserved node that promotes longevity in response to mitochondrial stress

Spatiotemporal sequence of mesoderm and endoderm lineage segregation during mouse gastrulation

Single-cell RNA sequencing reveals time- and sex-specific responses of spinal cord microglia to peripheral nerve injury and links ApoE to neuropathic pain

Single cells RNA-Seq of CD45+ cells during Staphylococcus aureus craniotomy infection

Macrophage-derived thrombospondin1 promotes obesity-associated non-alcoholic fatty liver disease

Genome editing demonstrates that the -5 kb Nanog enhancer regulates Nanog expression by modulating RNAPII initiation and/or recruitment

Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer [bulk RNA-seq]

Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer

Defining a critical Nanog enhancer using chromatin-focused approaches identifies RNAPII recruitment as required for expression [-5delRNASeq]

DLBCL-reminiscent MyD88- or CARD11-mutant aggressive B-cell lymphomas exhibit strong pro-senescent and immune-evasive phenotypes [part2]

DLBCL-reminiscent MyD88- or CARD11-mutant aggressive B-cell lymphomas exhibit strong pro-senescent and immune-evasive phenotypes [part1]

DLBCL-reminiscent MyD88- or CARD11-mutant aggressive B-cell lymphomas exhibit strong pro-senescent and immune-evasive phenotypes

Area postrema cell types that mediate nausea-associated behaviors

Alzheimer’s-associated PU.1 expression levels regulate microglial inflammatory response

Alleviating FGF19’s tumorigenic risk by suppressing its FGF Receptor dimerization ability

A cell competition-based drug screen identifies a novel compound that targets c-Myc addiction of leukemia cells